RALEIGH, N.C. — Ivermectin does not reduce the length of COVID-19 symptoms or hospitalizations, a large clinical trial headed by Duke researchers suggests.
The research was posted online Sunday, but has not yet been reviewed by a scientific journal. This is the largest randomized trial to evaluate ivermectin’s effectiveness for patients with mild to moderate COVID-19 symptoms, enrolling more than 1,500 people from across the country.
The results are in line with a growing body of research that suggests ivermectin — a drug hailed as a miracle cure despite warnings from the medical establishment — is not an effective treatment for COVID-19.
